These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27659035)

  • 1. Coeliac disease: immunogenicity studies of barley hordein and rye secalin-derived peptides.
    Wahab WA; Šuligoj T; Ellis J; Côrtez-Real B; Ciclitira PJ
    Int J Exp Pathol; 2016 Aug; 97(4):303-309. PubMed ID: 27659035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of clinical and immune reactivity to barley and rye ingestion in children with coeliac disease.
    Hardy MY; Russell AK; Pizzey C; Jones CM; Watson KA; La Gruta NL; Cameron DJ; Tye-Din JA
    Gut; 2020 May; 69(5):830-840. PubMed ID: 31462555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rye gamma-70 and gamma-35 secalins and barley gamma-3 hordein cross-react with omega-5 gliadin, a major allergen in wheat-dependent, exercise-induced anaphylaxis.
    Palosuo K; Alenius H; Varjonen E; Kalkkinen N; Reunala T
    Clin Exp Allergy; 2001 Mar; 31(3):466-73. PubMed ID: 11260160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.
    Stenman SM; Lindfors K; Venäläinen JI; Hautala A; Männistö PT; Garcia-Horsman JA; Kaukovirta-Norja A; Auriola S; Mauriala T; Mäki M; Kaukinen K
    Clin Exp Immunol; 2010 Aug; 161(2):242-9. PubMed ID: 20560983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar Responses of Intestinal T Cells From Untreated Children and Adults With Celiac Disease to Deamidated Gluten Epitopes.
    Ráki M; Dahal-Koirala S; Yu H; Korponay-Szabó IR; Gyimesi J; Castillejo G; Jahnsen J; Qiao SW; Sollid LM
    Gastroenterology; 2017 Sep; 153(3):787-798.e4. PubMed ID: 28535873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ingestion of oats and barley in patients with celiac disease mobilizes cross-reactive T cells activated by avenin peptides and immuno-dominant hordein peptides.
    Hardy MY; Tye-Din JA; Stewart JA; Schmitz F; Dudek NL; Hanchapola I; Purcell AW; Anderson RP
    J Autoimmun; 2015 Jan; 56():56-65. PubMed ID: 25457306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease.
    Hardy MY; Henneken LM; Russell AK; Okura Y; Mizoroki A; Ozono Y; Kobayashi S; Murakami Y; Tye-Din JA
    Clin Immunol; 2024 Jul; 264():110259. PubMed ID: 38768856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the putative immunodominant T cell epitopes in coeliac disease.
    Ellis HJ; Pollock EL; Engel W; Fraser JS; Rosen-Bronson S; Wieser H; Ciclitira PJ
    Gut; 2003 Feb; 52(2):212-7. PubMed ID: 12524402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa.
    Bracken SC; Kilmartin C; Wieser H; Jackson J; Feighery C
    Aliment Pharmacol Ther; 2006 May; 23(9):1307-14. PubMed ID: 16629935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease.
    Tye-Din JA; Stewart JA; Dromey JA; Beissbarth T; van Heel DA; Tatham A; Henderson K; Mannering SI; Gianfrani C; Jewell DP; Hill AV; McCluskey J; Rossjohn J; Anderson RP
    Sci Transl Med; 2010 Jul; 2(41):41ra51. PubMed ID: 20650871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains.
    Vader LW; Stepniak DT; Bunnik EM; Kooy YM; de Haan W; Drijfhout JW; Van Veelen PA; Koning F
    Gastroenterology; 2003 Oct; 125(4):1105-13. PubMed ID: 14517794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of enzymatically hydrolyzed prolamins from wheat, rye, and barley as references for the immunochemical quantitation of partially hydrolyzed gluten.
    Gessendorfer B; Koehler P; Wieser H
    Anal Bioanal Chem; 2009 Nov; 395(6):1721-8. PubMed ID: 19763549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic, immunostimulatory and antagonist gluten peptides in celiac disease.
    Silano M; Vincentini O; De Vincenzi M
    Curr Med Chem; 2009; 16(12):1489-98. PubMed ID: 19355902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiac disease: how complicated can it get?
    Tjon JM; van Bergen J; Koning F
    Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the immune response to barley in celiac disease: Biased and public T-cell receptor usage to a barley unique and immunodominant gluten epitope.
    Dahal-Koirala S; Neumann RS; Jahnsen J; Lundin KEA; Sollid LM
    Eur J Immunol; 2020 Feb; 50(2):256-269. PubMed ID: 31628754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Antibodies for Grain-Specific Gluten Detection.
    Sharma GM; Rallabhandi P; Williams KM; Pahlavan A
    J Food Sci; 2016 Mar; 81(3):T810-6. PubMed ID: 26878584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye.
    McGough N; Cummings JH
    Proc Nutr Soc; 2005 Nov; 64(4):434-50. PubMed ID: 16313685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing safety of germinated rye sourdough in a celiac disease model based on the adoptive transfer of prolamin-primed memory T cells into lymphopenic mice.
    Freitag TL; Loponen J; Messing M; Zevallos V; Andersson LC; Sontag-Strohm T; Saavalainen P; Schuppan D; Salovaara H; Meri S
    Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G526-34. PubMed ID: 24458020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.
    Molberg O; Kett K; Scott H; Thorsby E; Sollid LM; Lundin KE
    Scand J Immunol; 1997 Sep; 46(3):103-9. PubMed ID: 9315123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the safety of ancient strains of wheat in coeliac disease reveals heterogeneous small intestinal T cell responses suggestive of coeliac toxicity.
    Šuligoj T; Gregorini A; Colomba M; Ellis HJ; Ciclitira PJ
    Clin Nutr; 2013 Dec; 32(6):1043-9. PubMed ID: 23465776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.